Literature DB >> 31027544

Transfeminine Hormone Therapy.

Oksana Hamidi1, Caroline J Davidge-Pitts2.   

Abstract

Transgender women often seek hormone therapy to attain feminine physical features congruent with their gender identity. The aim of feminizing hormone therapy (FHT) is to provide suppression of endogenous testosterone and to maintain estradiol levels within the normal female range. Overall, FHT is safe if provided under supervision of an experienced health care provider and has been shown to improve quality of life. Data on care of transgender women are scarce and high-quality evidence-based recommendations are lacking. This article aims to review the published literature on FHT and provide guidance to clinicians caring for transgender women.
Copyright © 2019 Elsevier Inc. All rights reserved.

Entities:  

Keywords:  Anti-androgen; Estrogen; Gender dysphoria; Gender incongruence; Gender-affirming hormone therapy; Transgender male-to-female

Year:  2019        PMID: 31027544     DOI: 10.1016/j.ecl.2019.02.001

Source DB:  PubMed          Journal:  Endocrinol Metab Clin North Am        ISSN: 0889-8529            Impact factor:   4.741


  3 in total

1.  SIGIS-SIAMS-SIE position statement of gender affirming hormonal treatment in transgender and non-binary people.

Authors:  A D Fisher; G Senofonte; C Cocchetti; G Guercio; V Lingiardi; M C Meriggiola; M Mosconi; G Motta; J Ristori; A M Speranza; M Pierdominici; M Maggi; G Corona; F Lombardo
Journal:  J Endocrinol Invest       Date:  2021-10-22       Impact factor: 4.256

2.  Population pharmacokinetics of tenofovir, emtricitabine and intracellular metabolites in transgender women.

Authors:  Asama Tanaudommongkon; Ayyappa Chaturvedula; Craig W Hendrix; Edward J Fuchs; Eugenie Shieh; Rahul P Bakshi; Mark A Marzinke
Journal:  Br J Clin Pharmacol       Date:  2022-03-25       Impact factor: 3.716

3.  An Approach to Nonsuppressed Testosterone in Transgender Women Receiving Gender-Affirming Feminizing Hormonal Therapy.

Authors:  Arvind Maheshwari; Todd Nippoldt; Caroline Davidge-Pitts
Journal:  J Endocr Soc       Date:  2021-04-16
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.